Pharmafile Logo
Pharmafocus logo
Advanced Search
alessandro_riva

Glenmark spinoff name Gilead VP Alessandro Riva as new CEO

March 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead’s Dr Alessandro Riva, is stepping down from his position as the company’s Executive Vice President, Oncology Therapeutics to head …

Appointment
gilead-sciences

Gilead’s Biktarvy maintains HIV suppression for 48 weeks in children and adolescents

March 7, 2019
Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 …

News
scotland-2016-aerial-clackmannan_tower_01

Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea

March 7, 2019
Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries

A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …

News
allergan

Allergan’s depression drug rapastinel fails to outperform placebo at Phase 3

March 7, 2019
Research and Development Allergan, FDA, depression, major depressive disorder, pharma, rapastinel

As Janssen celebrated the FDA approval of the first novel therapy for depression in three decades with Spravato, Allergan released …

News
nhs_andrew_tatlow

Public satisfaction with NHS falls to lowest point since 2007

March 7, 2019
Medical Communications England, King's, NHS, Nuffield, Scotland, UK, Wales, kings, public stisfaction

Public satisfaction with the NHS has fallen to lowest levels since 2007, according to analysis of the 2018 British Social …

News
66824841_14fb63a9e2_z

Médecins Sans Frontières (MSF)/ Doctors Without Borders calls on CEPI to revise ‘toothless’ access policy

March 6, 2019
Sales and Marketing CEPI, MSF, access, public health, tokyo, vaccines

The humanitarian organisation Médecins Sans Frontières (MSF) has called on The Coalition for Epidemic Preparedness Innovations (CEPI) to revise their …

News
scott_gottlieb

FDA Commissioner Scott Gottlieb announces resignation

March 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …

News
16854249705_06b9d59c29_z

Indian measles vaccination campaign saved tens of thousands of lives

March 6, 2019
Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines

A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …

News
spravato

Janssen’s party drug-based nasal spray becomes first new FDA-approved depression treatment in 30 years

March 6, 2019
Research and Development, Sales and Marketing Janssen, Spravato, depression, esketamine, pharma

The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s …

News

Postoperative radiation can triple survival in children with brain cancer

March 6, 2019
Research and Development brain cancer, children, epndymoma, oncology, paediatric brain cancer, radiation

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …

News

Women scientists receive $41,000 less in funding than men, study shows

March 6, 2019
Research and Development NIH, funding, international womens day, management, science, women

Women scientists receive $41,000 less in federal funding than men, according to a study of nearly 54,000 grants to first …

News
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …

Appointment
shutterstock_38078521

Akcea and Ionis’ Waylivra nets CHMP approval in ultra-rare familial chylomicronaemia syndrome

March 5, 2019
Manufacturing and Production, Sales and Marketing Akcea, FCS, Ionis, familial chylomicronemia syndrome, pharma, rare disease

Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra (volanesorsen) has been recommended by the EMA’s Committee …

News
novartis_side_building

Novartis set to offer 14 weeks paternity leave

March 5, 2019
Manufacturing and Production Novartis, company culture, paternity leave, work

Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of …

News
1920px-hiv-budding-color

London man becomes second in world to be cured of HIV

March 5, 2019
Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient

A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …

News
novartis_side_building

Novartis’ Cosentyx tops Janssen’s Stelara in moderate-to-severe psoriasis trial

March 5, 2019
Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma, psoriasis

New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating the …

News
920x920

OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019
Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …

News

The cutting edge of cancer research

March 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, oncology

While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …

Feature
abbvie_0

AbbVie’s Skyrizi scoops up CHMP recommendation for moderate to severe plaque psoriasis

March 4, 2019
Sales and Marketing AbbVie, pharma, psoriasis

AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for Human Use (CHMP), …

News

Indian government set to colour code generic medicines

March 4, 2019
Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales

As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026